跳至主要内容
临床试验/DRKS00004909
DRKS00004909进行中(未招募)未知

Side effects of Tramadol and Tilidine in Cancer Pain Patients – A prospective randomized double blinded clinical trial - TiTa

niversitätsklinikum Freiburg - Anästhesiologie0 个研究点目标入组 61 人开始时间: 2013年5月13日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
61

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • cancer pain patients with moderate to severe pain, age > 18 years, sufficient mental, physical and linguistic abilities to cooperate at the study, signed informed consent

排除标准

  • contraindication for tilidine or tramadol (allergy against a component of tilidine or tramadol, pregnancy or lactation, severe hepatic or renal impairment (CHILD C; GFR < 15ml/min), seizure disorder, drug abuse, taking of MAO-inhibitors), acute interventional pain (e.g. postoperative pain), indication for pain therapy with opioids of WHO step 3

研究者

发起方
niversitätsklinikum Freiburg - Anästhesiologie

相似试验